190 related articles for article (PubMed ID: 32250211)
41. Cancer stem cell-targeted therapeutics and delivery strategies.
Ahmad G; Amiji MM
Expert Opin Drug Deliv; 2017 Aug; 14(8):997-1008. PubMed ID: 27866420
[TBL] [Abstract][Full Text] [Related]
42. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
43. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
44. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
45. Nanomedicine in cancer stem cell therapy: from fringe to forefront.
Tabassum N; Verma V; Kumar M; Kumar A; Singh B
Cell Tissue Res; 2018 Dec; 374(3):427-438. PubMed ID: 30302547
[TBL] [Abstract][Full Text] [Related]
46. Chemical approaches to targeting drug resistance in cancer stem cells.
Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
[TBL] [Abstract][Full Text] [Related]
47. Selective Targeting and Eradication of LGR5
Cao J; Li C; Wei X; Tu M; Zhang Y; Xu F; Xu Y
Mol Cancer Ther; 2018 Jul; 17(7):1475-1485. PubMed ID: 29695632
[TBL] [Abstract][Full Text] [Related]
48. Targeted Drug Delivery to Cancer Stem Cells through Nanotechnological Approaches.
Sun W; Chen G; Du F; Li X
Curr Stem Cell Res Ther; 2021; 16(4):367-384. PubMed ID: 33023455
[TBL] [Abstract][Full Text] [Related]
49. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
50. Implication of cancer stem cells in cancer drug development and drug delivery.
Chow EK
J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
[TBL] [Abstract][Full Text] [Related]
51. Existing drugs and their application in drug discovery targeting cancer stem cells.
Lv J; Shim JS
Arch Pharm Res; 2015 Sep; 38(9):1617-26. PubMed ID: 26152874
[TBL] [Abstract][Full Text] [Related]
52. The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.
Jain H; Dhawan P; Rao S; Lalwani N; Shand H
Anticancer Agents Med Chem; 2023; 23(4):368-382. PubMed ID: 36056850
[TBL] [Abstract][Full Text] [Related]
53. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
[TBL] [Abstract][Full Text] [Related]
54. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
55. Next-generation nanotheranostics targeting cancer stem cells.
Reda A; Hosseiny S; El-Sherbiny IM
Nanomedicine (Lond); 2019 Sep; 14(18):2487-2514. PubMed ID: 31490100
[TBL] [Abstract][Full Text] [Related]
56. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
57. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
[TBL] [Abstract][Full Text] [Related]
58. Cancer Stem Cells: Root of the Evil.
Erkisa M; Karakas D; Ulukaya E
Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
[TBL] [Abstract][Full Text] [Related]
59. Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
Maiuthed A; Chantarawong W; Chanvorachote P
Anticancer Res; 2018 Jul; 38(7):3797-3809. PubMed ID: 29970499
[TBL] [Abstract][Full Text] [Related]
60. Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z; Gabrisova V; Kucerova L
Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
